CannaReporter

14/10/2025

During the 16th Public Meeting of the Board of Directors, the Brazilian National Health Security Agency Anvisa once again requested an extension to comply with the Superior Tribunal de Justiça (STJ) decision, which authorized the cultivation of cannabis for medicinal and pharmaceutical purposes.

The Court had already demanded regulation of the cultivation last year, but ANVISA requested a postponement until September of this year.

However, once again, ANVISA failed to comply, claiming it was impossible to create a regulatory framework for the industry in such a short timeframe, and requested a further extension.

The THC limit is one of the most sensitive points of this regulation.

Read this article from João Costa in the link below ⬇️

Reading Time: 4 minutesEditor's note: Pedro Sabaciauskis' statements regarding meetings with associations were included on 10/13 at 14:43 pm. During the 16th Public Meeting of the Collegiate Board, the Brazilian National Health Security Agency (ANVISA) once again requested an extension of the deadli...

02/10/2025

At the end of the Portugal Medical Cannabis 2025 conference day in Lisbon, a heated debate took place which was the most sui generis of the entire event. Because it’s a year to mark two important dates, the roundtable’s theme was “100 Years of Prohibition, 25 of Decriminalization in Portugal: Future Paths,” and it was something those who attended will hardly forget.

Find out why in this summary article of this special session.

Read more at CannaReporter.eu

02/10/2025

The second edition of the H**p for the Future conference kicks off tomorrow in Reykjavik, an event bringing together international experts in industrial h**p, medicinal cannabis, sustainability, and public policy.

Organized by the Icelandic H**p Association, the meeting will take place on October 2nd and 3rd, 2025, at the historic Iðnó venue in the center of the Icelandic capital. The event will also be streamed live.

Follow this link or click on the stories: https://www.muvi.tv/live/91fe9602b7wn

24/09/2025

𝟭𝟬𝟬 𝗬𝗲𝗮𝗿𝘀 𝗼𝗳 𝗪𝗼𝗿𝗹𝗱’𝘀 𝗣𝗿𝗼𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻, 𝟮𝟱 𝗼𝗳 𝗗𝗲𝗰𝗿𝗶𝗺𝗶𝗻𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗣𝗼𝗿𝘁𝘂𝗴𝗮𝗹: 𝗙𝘂𝘁𝘂𝗿𝗲 𝗣𝗮𝘁𝗵𝘀
📅 September 25 | 19:00 – 20:00
📍 Casa do Alentejo, Lisbon

In 2025, the world marks a century of international drug prohibition, while Portugal commemorates 25 years of its pioneering decriminalization model — a policy that has been widely studied and referenced around the globe. This panel will reflect on the lessons learned from both milestones and discuss what lies ahead for drug policy, with a focus on cannabis.

The discussion will explore key themes such as:

The successes and limitations of Portugal’s decriminalization approach.

How international prohibition has shaped public health, justice systems, and cannabis policy.

The political, social, and scientific perspectives influencing the next steps for reform.

Possible future paths for Portugal and Europe in balancing public health, personal freedom, and regulation.

Bringing together voices from academia, policy, analysis and politics, this debate will address how Portugal’s experience can inform global reform and what role cannabis regulation might play in the next chapter of drug policy.

23/09/2025

𝗣𝗧𝗠𝗖𝟮𝟱 𝗢𝗽𝗲𝗻𝗶𝗻𝗴 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 - 𝗗𝗿. 𝗩𝗮𝘀𝗰𝗼 𝗕𝗲𝘁𝘁𝗲𝗻𝗰𝗼𝘂𝗿𝘁 - 𝗜𝗻𝗳𝗮𝗿𝗺𝗲𝗱 𝗜.𝗣.

Many professionals working in the medical cannabis sector face questions about licensing procedures and regulatory frameworks in Portugal. To provide clarity and guidance, Dr. Vasco Bettencourt, Director of the Licensing Unit and Coordinator of the Cannabis Office for Medicinal Purposes at Infarmed — the Portuguese Authority for Medicines and Health Products I.P. — will open the session at PTMC 2025, from 10:30 to 11:00 a.m..

In his presentation, Dr. Bettencourt will share an overview of the evolution of the cannabis industry in Portugal over the past year, highlighting regulatory developments, licensing activity and the main challenges and opportunities identified by Infarmed.

This will be a unique opportunity for participants to gain first-hand insights directly from the regulator and better understand the future direction of the Portuguese medical cannabis market. A round of Q&A will follow, allowing attendees to address specific questions.

22/09/2025

𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗖𝗮𝗻𝗻𝗮𝗯𝗶𝘀 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀 𝗮𝗻𝗱 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀
📅 September 25 | 11:00 – 12:00
📍 Sociedade de Geografia de Lisboa

𝗦𝘂𝗺𝗺𝗮𝗿𝘆:
This session will focus on the intersection of pharmaceutical science and cannabis, exploring how innovation can transform the plant into standardized, safe and effective medicines. The debate will highlight the latest advances in formulation, delivery methods, clinical research and product development, while also addressing regulatory hurdles and quality standards.

𝗞𝗲𝘆 𝘁𝗵𝗲𝗺𝗲𝘀 𝗳𝗼𝗿 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻:
👉 How pharmaceutical innovation can improve patient outcomes and expand therapeutic options.
👉 The role of rigorous testing, research and compliance in ensuring product quality and safety.
👉 Scientific and technological challenges that remain in the development of cannabis-based medicines.
👉 The opportunities for Europe to position itself as a leader in pharmaceutical cannabis innovation.

The goal of this panel is to bring different perspectives together (from science and research to industry and consultancy) to better understand how cannabis can integrate into modern medicine and what steps are needed to advance the field.

21/09/2025

𝗡𝗲𝘄 𝗦𝗽𝗲𝗮𝗸𝗲𝗿 𝗳𝗼𝗿 𝗣𝗧𝗠𝗖𝟮𝟱

Cláudia Estêvão is a Member of the Assembly of the Republic for the CHEGA Party, elected in the Setúbal constituency. A registered nurse with a 30-year career in the National Health Service (SNS), where she holds management positions, she holds a master's degree in Health Management and has dedicated herself to defending the Portuguese SNS, transparency and community outreach. In Parliament, she serves on the Health Committee and has focused her work on public health, access to medicines and community outreach policies.

🗓️ September 25–26
📍 Lisbon, Portugal
🎟️ Get your tickets now at ptmc.pt

19/09/2025

We're happy to announce Helena Correia as a PTMC Speaker.
Helena Correia is a pharmacist and independent regulatory affairs consultant with over 15 years of experience in pharmaceutical regulatory and quality affairs. She actively supports the development of the medicinal cannabis industry in Portugal and internationally, advising companies on licensing, product development and registration, and strategic regulatory planning for market access across global jurisdictions.
She holds a degree in Pharmaceutical Sciences and a Master’s in Technology of Medicines from the University of Coimbra, along with postgraduate qualifications in Herbal Medicinal Products and Regulatory Affairs from the Universities of Coimbra and Lisbon.
🗓️ September 25–26
📍 Lisbon, Portugal
🎟️ https://ptmc.pt/

17/09/2025

Waiting for PTMC25? So are we, but until then we still have lots of news to share, starting with today's new speaker.
João Castel-Branco Goulão is currently the National Coordinator for Addictive Behaviours and Dependencies and Chair of the Institute on Addictive Behaviours and Dependencies, P.I. (Ministry of Health), the national governmental structure within the Health Ministry responsible for the coordination of policy on illicit drugs, alcohol and other dependencies without substance (gambling, internet).
A medical doctor by profession, Dr. Goulão has over 25 years’ experience regarding drug- related issues, working in this field since 1987 as general practitioner and since then all his professional life has been devoted to addictions and health.
He was also a member of the Portuguese Committee which, in 1999, prepared the report on which the first Portuguese Drug Strategy was based and that included the Law on decriminalization, into force since in 2021.
He has a long experience in addictions field at international level, not only at the European level, but also in the United Nations context. He is the Portuguese representative at EUDA Management Board and he was Chairman of the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) from 2009 to 2015. He was the Chair of the Pompidou Group of the Council of Europe for the period 2019-2022 and Chair of the Horizontal Drugs Group during the Portuguese Presidency of the European Union in 2021.
🗓️ September 25–26
📍 Lisbon, Portugal
🎟️ Secure your ticket, because seats are limited! 👉 https://ptmc.pt/

13/09/2025

Joining us at PTMC 25 is our new speaker, Amit, ready to share his unique insights and experience.
With over 12 years in the medical cannabis sector, Amit brings operational and
managerial expertise across international markets. Before founding Portocanna in 2019,
he advised global cannabis companies and served as COO at Israel’s leading processing
company, supplying thousands of patients monthly.
At Portocanna, he has driven its growth into one of Europe’s leading manufacturers.
Under his leadership, the company achieved EU-GMP certification, developed an
in-house laboratory, established an R&D team, and scaled into large-scale operations,
with monthly processing volumes reaching several tons for distribution abroad.
🗓️ September 25–26
📍 Lisbon, Portugal
🎟️ Secure your ticket, because seats are limited! 👉 https://ptmc.pt/

12/09/2025

The Judiciary Police arrested and extradited from the Netherlands to Portugal a 48-year-old man suspected of being the leader of a criminal group dedicated to cannabis trafficking in several European and African markets.

According to a press release issued today, “the Judicial Police, through the National Unit to Combat Drug Trafficking and the International Cooperation Unit, carried out an international police operation, during which it was possible to track down and arrest one of the main leaders of a criminal group dedicated to the introduction of large quantities of cannabis into several European and African markets.”

Read more at CannaReporter.eu

10/09/2025

The Cannabis Supply Chain: International Market's Trends
From cultivation and processing to distribution and patient access, the cannabis supply chain stands as a key issue in today’s global industry. Shaped by shifting regulations, new technologies and rising demand, it plays a central role in determining how patients, companies and investors interact with the cannabis market. This panel brings together leading experts to analyze current international trends, examine challenges such as compliance and standardization and highlight opportunities for innovation and growth across the value chain.
Moderator: Arnau Valdovinos (Cannamonitor)
Speakers: Alfredo Pascual (Analyst), Rob Smallman (Global Cannabis Exchange), Natalia Lopez (Big Leaf Consultants), Sita Schubert (EUMCA)